Multi-center randomized clinical study on Shenqi-fuzheng injection combined with chemotherapy in the treatment for lung cancer.
- Author:
Hong-Sheng LIN
1
;
Dao-Rui LI
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; administration & dosage; therapeutic use; Antineoplastic Combined Chemotherapy Protocols; therapeutic use; Carcinoma, Non-Small-Cell Lung; drug therapy; physiopathology; Cisplatin; therapeutic use; Drugs, Chinese Herbal; administration & dosage; therapeutic use; Female; Humans; Infusions, Intravenous; Lung Neoplasms; drug therapy; physiopathology; Male; Medicine, Chinese Traditional; Middle Aged; Paclitaxel; Phytotherapy; Quality of Life; Taxoids; therapeutic use; Young Adult
- From: Chinese Journal of Oncology 2007;29(12):931-934
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the effect of Shenqi-fuzheng injection combined with chemotherapy on the quality of life in lung cancer patient.
METHODS232 pathologically confirmed nonsmall cell lung cancer patients were enrolled into this multi-center randomized trial. Of these 232 patients, 116 cases were treated with chemotherapy alone (chemotherapy group), another 116 with chemotherapy combined with Shenqi-fuzheng injection produced by Lizhu Company (Shenqi-fuzheng group). Life quality of these patients were evaluated using the QOL scale of European Organization for Research on Treatment of Cancer (QLQ-C30) and the functional living index-cancer.
RESULTSCompared with chemotherapy group, Life quality and symptoms were improved in the Shenqi-fuzheng group, which including lassitude, deficient in breath, pain, fullness in chest and hypochondrium, excessive phlegm, cough, complexion whiteness. Response rate to chemotherapy was also improved. No AE and SAE were observed in the Shenqi-fuzheng group.
CONCLUSIONShenqi-fuzheng injection combined with chemotherapy is safe and effective in the treatment for non-small cell lung cancer.
